Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03365531
What this trial is testing

RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLDObesityDiabetes Mellitus, Type 2
University of Florida 7
Not applicableNot Yet RecruitingNCT06668753
What this trial is testing

Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Who this might be right for
Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Assiut University 114
Not applicableStudy completedNCT04283942
What this trial is testing

Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism

Who this might be right for
Fatty Liver DiseaseType 2 DiabetesImpaired Glucose Regulation
Shanghai Zhongshan Hospital 60
Not applicableUnknownNCT06338969
What this trial is testing

The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis

Who this might be right for
Obesity, MorbidNASHKetosis+2 more
The Society of Bariatric and Metabolic Surgeons of Kazakhstan 150
Post-approval studies (Phase 4)UnknownNCT06060886
What this trial is testing

Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis

Who this might be right for
SchizophreniaTreatment-resistant SchizophreniaSide Effect+4 more
Consorcio Centro de Investigación Biomédica en Red (CIBER) 244
Testing effectiveness (Phase 2)UnknownNCT04255069
What this trial is testing

Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
TaiwanJ Pharmaceuticals Co., Ltd 300
Testing effectiveness (Phase 2)Ended earlyNCT01244503
What this trial is testing

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

Who this might be right for
Metabolic SyndromeNonalcoholic Fatty Liver Disease
Virginia Commonwealth University 61
Testing effectiveness (Phase 2)Study completedNCT04342793
What this trial is testing

Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH

Who this might be right for
Nonalcoholic Steatohepatitis
AngioLab, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01205087
What this trial is testing

Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome

Who this might be right for
Nonalcoholic Steatohepatitis
Hadassah Medical Organization 36
Not applicableUnknownNCT05054712
What this trial is testing

Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Non-alcoholic Fatty Liver DiseaseGlycogen HepatopathyType 1 Diabetes+1 more
Consorci Sanitari de l'Alt Penedès i Garraf 250
Not applicableEnrolling By InvitationNCT06334666
What this trial is testing

The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.

Who this might be right for
Daily Step CountMASLDBMI+5 more
Mahidol University 86
Not applicableStudy completedNCT04872777
What this trial is testing

Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH

Who this might be right for
Non-alcoholic Steatohepatitis
Milton S. Hershey Medical Center 40
Not applicableUnknownNCT05359471
What this trial is testing

Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD

Who this might be right for
Visceral SteatosisHivNAFLD
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Not applicableStudy completedNCT04785937
What this trial is testing

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseSteatohepatitis, NonalcoholicLiver Fibroses
Azienda USL Reggio Emilia - IRCCS 28
Testing effectiveness (Phase 2)UnknownNCT02201160
What this trial is testing

Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric Patients

Who this might be right for
Non Alcoholic Fatty Liver Disease (NAFLD)
St. Justine's Hospital 30
Not applicableStudy completedNCT00815009
What this trial is testing

Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
San Antonio Military Medical Center 56
Not applicableStudy completedNCT04042142
What this trial is testing

Glucagon Resistance in Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisGlucose Metabolism Disorders
University of Aarhus 28
Not applicableUnknownNCT05563259
What this trial is testing

Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseCognitive Impairment
Yan Bi 500
Not applicableNot Yet RecruitingNCT06691529
What this trial is testing

Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease

Who this might be right for
Fatty Liver DiseaseChronic Glomerular Disease
Assiut University 500
Not applicableUnknownNCT06159257
What this trial is testing

Evaluation of the Physiological Stability Variability and Robustness of NIS4

Who this might be right for
Evaluate the Physiological Stability of NIS4 Biomarker Between the Fed and Fasting State in Patients With the Target Condition (NAFLD)
CerbaXpert 50
Next Page